- Home
- TOVX vs NUWE Comparison
TOVX vs NUWE Comparison
Compare TOVX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- NUWE
- Stock Information
- Founded
- TOVX 2001
- NUWE 1999
- Country
- TOVX United States
- NUWE United States
- Employees
- TOVX N/A
- NUWE N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TOVX Health Care
- NUWE Health Care
- Exchange
- TOVX Nasdaq
- NUWE Nasdaq
- Market Cap
- TOVX 3.8M
- NUWE 3.9M
- IPO Year
- TOVX 2006
- NUWE N/A
- Fundamental
- Price
- TOVX $0.50
- NUWE $6.88
- Analyst Decision
- TOVX Hold
- NUWE Strong Buy
- Analyst Count
- TOVX 1
- NUWE 1
- Target Price
- TOVX N/A
- NUWE $714.00
- AVG Volume (30 Days)
- TOVX 170.1K
- NUWE 121.9K
- Earning Date
- TOVX 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- TOVX N/A
- NUWE N/A
- EPS Growth
- TOVX N/A
- NUWE N/A
- EPS
- TOVX N/A
- NUWE N/A
- Revenue
- TOVX N/A
- NUWE $8,787,000.00
- Revenue This Year
- TOVX N/A
- NUWE $6.53
- Revenue Next Year
- TOVX N/A
- NUWE $51.63
- P/E Ratio
- TOVX N/A
- NUWE N/A
- Revenue Growth
- TOVX N/A
- NUWE N/A
- 52 Week Low
- TOVX $0.40
- NUWE $6.73
- 52 Week High
- TOVX $7.37
- NUWE $197.40
- Technical
- Relative Strength Index (RSI)
- TOVX 45.57
- NUWE 25.34
- Support Level
- TOVX $0.42
- NUWE $7.20
- Resistance Level
- TOVX $0.48
- NUWE $10.08
- Average True Range (ATR)
- TOVX 0.03
- NUWE 0.99
- MACD
- TOVX 0.02
- NUWE 0.64
- Stochastic Oscillator
- TOVX 88.67
- NUWE 10.66
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.